U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Jerky ocular pursuit movements

MedGen UID:
342908
Concept ID:
C1853558
Finding
Synonym: Jerky smooth pursuit
 
HPO: HP:0008003

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVJerky ocular pursuit movements

Conditions with this feature

Autosomal recessive ataxia, Beauce type
MedGen UID:
343973
Concept ID:
C1853116
Disease or Syndrome
SYNE1 deficiency comprises a phenotypic spectrum that ranges from autosomal recessive cerebellar ataxia at the mild end to arthrogryposis multiplex congenita (AMC) at the severe end. SYNE1-deficient cerebellar ataxia, the most commonly recognized manifestation of SYNE1 deficiency to date, is a slowly progressive disorder typically beginning in adulthood (age range 6-45 years). While some individuals have a pure cerebellar syndrome (i.e., cerebellar ataxia, dysarthria, dysmetria, abnormalities in ocular saccades and smooth pursuit), many also have upper motor neuron dysfunction (spasticity, hyperreflexia, Babinski sign) and/or lower motor neuron dysfunction (amyotrophy, reduced reflexes, fasciculations). Most individuals develop features of the cerebellar cognitive and affective syndrome (i.e., significant deficits in attention, executive functioning, verbal working memory, and visuospatial/visuoconstructional skills). The two less common phenotypes are SYNE1-deficient childhood-onset multisystem disease (ataxia, upper and lower motor neuron dysfunction, muscle weakness and wasting, intellectual disability) and SYNE1-deficient arthrogryposis multiplex congenita (decreased fetal movements and severe neonatal hypotonia associated with multiple congenital joint contractures including clubfoot).
Spinocerebellar ataxia type 13
MedGen UID:
344297
Concept ID:
C1854488
Disease or Syndrome
Spinocerebellar ataxia type 13 (SCA13) is a phenotypic spectrum that includes both non-progressive infantile-onset ataxia and progressive childhood-onset and adult-onset cerebellar ataxia. Three phenotypes are seen: Cerebellar hypoplasia with non-progressive infantile-onset limb, truncal, and gait ataxia with mild-to-moderate intellectual disability and occasionally seizures and/or psychiatric manifestations. Cognition and motor skills improve over time. Childhood-onset slowly progressive cerebellar atrophy with slowly progressive cerebellar ataxia and dysarthria, delayed motor milestones, and mild-to-moderate intellectual disability. Adult-onset progressive cerebellar atrophy with progressive ataxia and spasticity.
Spinocerebellar ataxia type 11
MedGen UID:
346799
Concept ID:
C1858351
Disease or Syndrome
Spinocerebellar ataxia type 11 (SCA11) is characterized by progressive cerebellar ataxia and abnormal eye signs (jerky pursuit, horizontal and vertical nystagmus). Pyramidal features are seen on occasion. Peripheral neuropathy and dystonia are rare. Six families have been reported to date, one each from the UK, Pakistan, France, Germany, Denmark, and China. Age of onset ranged from early childhood to the mid-40s. Life span is thought to be normal.
Hereditary spastic paraplegia 46
MedGen UID:
473687
Concept ID:
C2828721
Disease or Syndrome
Autosomal recessive spastic paraplegia-46 (SPG46) is a neurodegenerative disorder characterized by onset in childhood of slowly progressive spastic paraplegia and cerebellar signs. Some patients have cognitive impairment, cataracts, and cerebral, cerebellar, and corpus callosum atrophy on brain imaging (summary by Boukhris et al., 2010 and Martin et al., 2013). For a discussion of genetic heterogeneity of autosomal recessive spastic paraplegia, see SPG5A (270800).
Spinocerebellar ataxia 46
MedGen UID:
1624251
Concept ID:
C4540404
Disease or Syndrome
A rare autosomal dominant cerebellar ataxia with characteristics of slowly progressive late-onset cerebellar ataxia variably combined with sensory axonal neuropathy. Patients may present gait and limb ataxia, dysarthria, abnormal oculomotor function and distal sensory impairment. Cerebellar atrophy is typically mild or absent.
Autosomal recessive spinocerebellar ataxia 14
MedGen UID:
1636182
Concept ID:
C4706415
Disease or Syndrome
Autosomal recessive spinocerebellar ataxia-14 (SCAR14) is a neurologic disorder characterized by delayed psychomotor development, severe early-onset gait ataxia, eye movement abnormalities, cerebellar atrophy on brain imaging, and impaired intellectual development (summary by Lise et al., 2012).
Spinocerebellar ataxia, autosomal recessive 27
MedGen UID:
1672866
Concept ID:
C5193058
Disease or Syndrome
Autosomal recessive spinocerebellar ataxia-27 (SCAR27) is an adult-onset neurologic disorder characterized by gait difficulties and other cerebellar signs, such as eye movement abnormalities, dysarthria, and difficulty writing. The disorder is progressive, and some patients may lose independent ambulation. Additional features include spasticity of the lower limbs and cognitive impairment. Brain imaging shows cerebellar atrophy (summary by Eidhof et al., 2018).
Trichothiodystrophy 8, nonphotosensitive
MedGen UID:
1794267
Concept ID:
C5562057
Disease or Syndrome
Nonphotosensitive trichothiodystrophy-8 (TTD8) is characterized by brittle hair and nails and scaly skin, accompanied by failure to thrive, microcephaly, and neuromotor developmental delay. Hair analysis shows low sulfur content, and skin fibroblasts demonstrate normal DNA repair efficiency after UV irradiation (Botta et al., 2021). For a general phenotypic description and discussion of genetic heterogeneity of trichothiodystrophy, see TTD1 (601675).

Recent clinical studies

Etiology

Galli J, Loi E, Strobio C, Micheletti S, Martelli P, Merabet LB, Pasini N, Semeraro F, Fazzi E; AS Collaborative Group
Brain Dev 2023 Feb;45(2):117-125. Epub 2022 Nov 4 doi: 10.1016/j.braindev.2022.10.003. PMID: 36344336
Wang HC, Chiu HC
Zhonghua Yi Xue Za Zhi (Taipei) 1991 Mar;47(3):161-8. PMID: 1848143

Diagnosis

Galli J, Loi E, Strobio C, Micheletti S, Martelli P, Merabet LB, Pasini N, Semeraro F, Fazzi E; AS Collaborative Group
Brain Dev 2023 Feb;45(2):117-125. Epub 2022 Nov 4 doi: 10.1016/j.braindev.2022.10.003. PMID: 36344336
Loy CT, Sweeney MG, Davis MB, Wills AJ, Sawle GV, Lees AJ, Tabrizi SJ
Mov Disord 2005 Nov;20(11):1521-3. doi: 10.1002/mds.20529. PMID: 16037935
Sztriha L, Al-Gazali LI, Aithala GR, Nork M
Pediatr Neurol 1999 Apr;20(4):274-81. doi: 10.1016/s0887-8994(98)00154-4. PMID: 10328276
Kirkham TH, Guitton D, Katsarkas A, Kline LB, Andermann E
Can J Neurol Sci 1979 May;6(2):167-72. doi: 10.1017/s0317167100119584. PMID: 487305

Therapy

Wang HC, Chiu HC
Zhonghua Yi Xue Za Zhi (Taipei) 1991 Mar;47(3):161-8. PMID: 1848143

Clinical prediction guides

Montagnese S, Gordon HM, Jackson C, Smith J, Tognella P, Jethwa N, Sherratt RM, Morgan MY
Hepatology 2005 Oct;42(4):772-81. doi: 10.1002/hep.20855. PMID: 16175619
Sztriha L, Al-Gazali LI, Aithala GR, Nork M
Pediatr Neurol 1999 Apr;20(4):274-81. doi: 10.1016/s0887-8994(98)00154-4. PMID: 10328276

Supplemental Content

Table of contents

    Clinical resources

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...